A5012523411- Respiratory viral infections research
- Pneumonia and Respiratory Infections
- Influenza Virus Research Studies
- Vaccine Coverage and Hesitancy
- Bacterial Infections and Vaccines
- HIV/AIDS Research and Interventions
- Viral gastroenteritis research and epidemiology
- Global Maternal and Child Health
- Data-Driven Disease Surveillance
- Immunodeficiency and Autoimmune Disorders
- Gastroesophageal reflux and treatments
- Parvovirus B19 Infection Studies
- Avian ecology and behavior
- Misinformation and Its Impacts
- Bird parasitology and diseases
- Social Media in Health Education
- Palliative Care and End-of-Life Issues
- Hepatitis Viruses Studies and Epidemiology
- HIV Research and Treatment
- Insects and Parasite Interactions
- COVID-19 epidemiological studies
- Virology and Viral Diseases
- Adolescent Sexual and Reproductive Health
- HIV, Drug Use, Sexual Risk
- Gastrointestinal disorders and treatments
Hunter New England Local Health District
2014-2020
Menzies School of Health Research
2009-2018
Charles Darwin University
2015-2018
Clinton Health Access Initiative
2018
New South Wales Department of Health
2014
The University of Melbourne
2006-2010
Papua New Guinea Institute of Medical Research
2010
In autumn 2002, an outbreak of probable psittacosis occurred among residents the Blue Mountains district, Australia. We conducted a case-control study to determine independent risk factors for by comparing exposures between hospitalized patients and other selected randomly from telephone directory. Of 59 case-patients with laboratory results supportive psittacosis, 48 participated in 310 controls. Independent were residence upper (odds ratio [OR] 15.2, 95% confidence interval [CI] 5.6-41.7),...
Vaxtracker is a web based survey for active post marketing surveillance of Adverse Events Following Immunisation. It designed to efficiently monitor vaccine safety new vaccines by early signal detection serious adverse events. The system automates contact with the parents or carers immunised children email and/or sms message their smart phone. A hyperlink on and text messages links exploring events following immunisation. concept was developed during 2011 (n = 21), piloted 2012 200) 2013...
Introduction In urban areas, crowded HIV treatment facilities with long patient wait times can deter patients from attending their clinical appointments and picking up medications, ultimately disrupting care compromising retention adherence. Methods Formative research at eight in Lusaka revealed that only 46% of stable were receiving a three-month refill supply antiretroviral drugs, despite it being national policy for adult patients. We designed quality improvement intervention to improve...
We assessed maternal 23-valent pneumococcal polysaccharide (23vPPV) vaccine efficacy (VE) against middle ear disease and carriage amongst Australian Indigenous infants. In an open label, allocation concealed, outcome-assessor blinded, community stratified, randomised controlled trial, healthy pregnant women aged 17–39 years in the Northern Territory of Australia received 23vPPV (1:1:1) at: 30–36 weeks gestation, birth, or were unvaccinated (ClinicalTrials.gov NCT00714064). Co-primary...
Background In 2013, Uganda adopted a test-and-treat policy for HIV patients 15 years or younger. Low retention rates among paediatric and adolescent antiretroviral therapy (ART) initiates could severely limit the impact of this new policy. This evaluation tested differentiated care model called Family Clinic Day (FCD), family-centered appointment scheduling health education intervention on patient adherence to monthly scheduling. Methods We conducted cluster randomized controlled trial, from...
Background We assessed the integration of early infant HIV diagnosis with expanded programme for immunization in a rural Zambian setting aim determining whether and postpartum maternal testing rates would increase without harming uptake. Methods In an unblinded, location stratified, cluster randomised controlled trial, 60 facilities Zambia's Southern Province were equally allocated to control group, Simple Intervention group that received sensitization meeting resupply commodities event...
Indigenous adults residing in the Northern Territory of Australia experience elevated rates invasive pneumococcal disease despite routine use 23-valent polysaccharide vaccine (23vPPV). We hypothesised that limited protection from 23vPPV may be due to hyporesponsiveness as a result failure repeated vaccination. To explore this possibility, we evaluated immune response first and second dose non-Indigenous adults.
Surveillance for intussusception (IS) has been recommended in countries using rotavirus vaccine, but can be resource intensive. There is little data about the relative severity of vaccine-associated IS compared with other cases. We collected detailed clinical on all cases to evaluate validity ICD coding routinely and case severity.Hospitalizations emergency department presentations coded as infants aged <12 months from July 1, 2007, June 30, 2010, were classified Brighton criteria by note...
Flutracking participation continued to grow, with a total of 33,947 participants in 2017 (a 9.5% increase from 2016). The majority completed their survey within 24 hours the email being sent (average 72.5% responses received hours). Overall, rate influenza-like illness (ILI) was higher and remained elevated for longer period compared previous years except 2009 pandemic. placed severity magnitude influenza season into historical context. Following highest number laboratory-notified cases on...
Indigenous children in Australia's Northern Territory are densely colonised with the pneumococcus within weeks of birth antecedent to a high prevalence acute lower respiratory infection (ALRI). We assessed impact 23-valent pneumococcal polysaccharide vaccine (23vPPV) pregnancy against infant ALRI this setting. In an open label, allocation concealed, outcome-assessor blinded, randomised controlled trial conducted Australia, healthy women aged 17–39 years were receive 23vPPV during (n = 75;...
Indigenous Australians experience one of the highest rates pneumococcal disease globally. In Northern Territory Australia, a unique government‐funded vaccination schedule for Australian adults comprising multiple lifetime doses polysaccharide vaccine is currently implemented. Despite this programme, do not appear to be declining, with concerns raised over potential immune hyporesponse associated use vaccine. We undertook study examine immunogenicity and function single repeat among compared...
Our commentary [1][1] was intended as a critical review of the evidence base provided by Anke Huss and colleagues’ meta-analysis. [2][2] We challenged what we perceived an implied recommendation for countries to cease vaccination programs with polysaccharide pneumococcal vaccine adults if
Following Australia’s severe influenza season in 2017, the health departments of states and territories commenced funding 2018 vaccine for all children aged six months to five years. As national immunisation register has recently been extended include recording vaccination age groups, community-based influenza-like illness (ILI) surveillance system, Flutracking, was used explore coverage participants. Flutracking participants respond a weekly survey about ILI from April October each year....